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Abstract. To meet the growing demands for the development of new molecular entities for discovering 
new drugs and materials, organic chemists have started working on many new concepts that can help to 
assimilate knowledge-based structural diversities more efficiently than ever before. Emulating the basic 
principles followed by Nature to build its vast repertoire of biomolecules, organic chemists are develop-
ing many novel multif nctional building blocks and using them to create ‘nature-lik ’ and yet unnatural 
organic molecules. Sugar amino acids constitute an important class of such polyfunctional scaffolds 
where the carboxyl, amino and hydroxyl termini provide an excellent opportunity to organic chemists to 
create structural diversities akin to Nature’s molecular arsenal. In recent years, sugar amino acids have 
been used extensively in the area of peptidomimetic studies. Advances made in the area of combinatorial 
chemistry can provide the necessary technological support for rapid compilations of sugar amino acid-
based libraries exploiting the diversities of their carbohydrate frameworks and well-developed so id-
phase peptide synthesis methods. This perspective article chronicles some of the recent applications of 
various sugar amino acids, furan amino acids, pyrrole amino acids etc. and many other related building 
blocks in wide-ranging peptidomimetic studies. 
 
Keywords. Sugar amino acids; furan amino acids; pyrrole amino acids; peptides; NMR; molecular  
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1. Introduction 
The spectacular advances in chemistry in the last 
century, especially in the area of organic synthes s,1,2 
have given us the ability to design unnatural mole-
cules, to predict their properties, and to build them 
in the laboratory, providing alternate ways to sup-
plement the traditional methods of finding bioactive 
molecules from nature.3–6 The traditional methods 
are not adequately equipped to rapidly assimilate 
new molecular structures, the increased demand for 
which is being critically felt today due to the alarm-
ing decline in the number of new chemical entities 
introduced every year as drugs in the past decade.7 
This has prompted chemists to work on alternate 
concepts to create new molecules in the laboratory to 
meet theirs growing demands. The expertise gained 
over the years in the areas of organic synthesis, bio-
logical sciences, the advances made in spectrosco ic 
and computational methods, rational drug-design 
concepts etc. are cleverly orchestrated to create de 
novo designer structures to provide leads in discov-
ering new drugs as well as new materials.8 However, 
the failure of the new techniques, like combinatorial 
chemistry and high throughput screening processes, 
to rapidly produce the much desired lead molecules 
in large numbers forced chemists to redefine their 
strategies.7,9 The initial assumption that diversity r-
lies on numbers is gradually being replaced today by 
generation of diversity based on detail knowledge of 
biological processes. It is being increasingly real-
ized that, instead of creating abstract molecules in 
millions, it is better to design new molecules by 
emulating the basic principles followed by Nature to 
build its vast repertoire of biomolecules. The funda-
me tal build ng blocks used by nature, like amino 
acids, sugars and nucleosides, can be amalgamated 
to produce nature-like, and yet unnatural, structural 
entities with multifunctional groups anchored on a 
single ensemble, based on which new molecules can 
be created. 
 Sugar amino acids represent an important class of 
such designer templates that have found an impor-
tant place in the area of peptidomimetic studies. The 
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emergence of these molecules as versatile and mul-
tifunctional synthetic building blocks has been re-
viewed by us and others few years back.10 In this 
perspective article, we wish to chronicle further  
developments in the wide-ranging applications of 
sugar amino acids and related building blocks in de-
signing molecules since then. 
 The sugar amino acids have a general structure 1 
as shown in figure 1. They are basically hybrids of 
carbohydrate and amino acids where amino and car-
boxyl functional groups have been incorporated at 
the two termini of regular 2,5- or 2,6-anhydro sugar 
frameworks. There are several adv nt ges of sugar 
amino acids as building blocks. 
 
(1) The rigid furan and pyran rings of these mole-
cules make them ideal candidates as non-peptide 
scaffolds in peptidomimetics where they can be eas-
ily incorporated by using their carboxyl and amino 
termini utilizing well-developed solid-phase or solu-
tion-phase peptide synthesis methods. 
(2) At the same time, it allows efficient exploitation 
of the structural diversities of carbohydrate mole-
cules. The presence of several chiral centers in these 
molecules can give rise to large number possible 
isomers that can be used to create combinatorial  
libraries of sugar amino acid-based molecular 
frameworks predisposed to fold into architecturally 
beautiful ordered structures, which may also have 
interesting properties.  
(3) The protected/unprotected hydroxyl groups of 
sugar rings can also influence the hydrophobic/ 
hydrophilic Nature of such molecular assemblies. 
 
The versatilities of these hybrid molecules named 
sugar amino acids, which were first reported in 
1955,11 and used in few occasions as peptide building 
blocks thereafter,12 were essentially first demon-
strated in 1994 by Kessler who used pyranoid sugar 
amino acids to make analogs of Leu-enk phalin and 
somatostatin.13 The details of that study were later  
 
 
Figure 1. The general structure of sugar amino acids. 
reported by them in 1996.14 In our laboratory, we 
focused our attention on the uses of furanoid sugar 
amino acids (2 in figure 2) in related studies15 and 
thes  were synthesized following a novel reaction 
path in which the oxidation of a primary hydroxyl 
group in a hexose-derived acyclic aziridinyl com-
pound with pyridinium dichromate was accompanied 
by an interesting rearrangement involving 5-exo SN2 
opening of the terminal aziridine ring by g-benz loxy 
oxygen with concomitant debenzylation, leadi g to 
th  furanoid framework of sugar amino acids (see 
figure 3).15 However, the credit for the first synthe-
sis of furanoid sugar amino acids, to the best of our 
knowledge, goes to Merrer and coworkers who re-
ported their preparation by a different route in  
 
 
 
Figure 2. The general structure of the furanoid sugar 
amino acids used by us. 
 
 
 
 
Figure 3. Synthesis of Gaa from its linear precursor 
(top), Gaa containing Leu-enkephalin analog 3 (middle) 
and the stereo view of the superimposed energy-mini-
mized structures (bottom) sampled during the constrained 
MD simulations of 3.15 
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   4 
Figure 4. Gaa containing gramicidin S analog 4 nd its crystal structure.19 (Crystal structure has been 
reprinted with permission from J. A . Chem. Soc. (2004) vol. 126(11), pp 3444–46, © 2004, American 
Chemical Society.) 
 
 
 
Figure 5. General trends of the intramolecular H-bond 
forming propensities of the 2,5-anydro (A and C) and  
2,5-imino (B and D) furanoid sugar amino acid contain-
ing peptides: A and B with free OH and 2,3-cis relation-
ship only; C with protected-OH, 2,3-cis or trans and 2,5- 
cis isomers only; D with protected-OH and 2,3-cis or 
trans isomer. 
 
1995.16 Many other methods for the synthesis of 
both furanoid and pyranoid sugar amino acids have 
been developed by various groups and dicusse  in 
detail earlier.10 
2. Sugar ring OHs as H-bond acceptors in  
furanoid sugar amino acids 
What distinguishes furanoid sugar amino acids from 
their pyranoid counterparts is the propensity of the ring 
hydroxyls in the former to participate in intramole-
cular hydrogen bonds with the main chain amides. 
 This was first demonstrated by us by inserting a 
glucose-derived furanoid sugar amino acid Gaa into 
the Gly–Gly segment of Leu- nkephalin to give an 
analog 3 (figure 3) that had structure very similar to 
the bioactive conformation of Leu-enkephalin. It 
was concluded by us based on extensive structural 
analysis of various peptidomimetic molecules con-
taining furanoid sugar amino acid scaffolds that the 
free hydroxyl groups on sugar rings prevent short 
linear peptides containing these molecules from 
adopting regular b-turn structures as these hydroxyl 
groups themselves act as hydrogen bond acceptors. 
Free hydroxyl groups on carbohydrate rings form 
intramelecular hydrogen bonds with adjacent hy-
droxyls, but in most of the cases they act as both H-
bond donor and acceptor in the same molecule.17 
Amino acids with hydroxyl groups in their side-
chains (serine, threonine) serve as acceptors only 
about 30% of the time.18 Moreover, an H-bond be-
tween main-chain NH ® side-chain OH leading to 
this type of turn structure is also very rare, mainly 
because of the free rotation about c1 in these amino 
acids. In sugar amino acids, unlike in serine and 
threonine, the hydroxyls are conformationally re-
stricted forcing them to participate in the formation 
of unusual secondary structures. Our finding has re-
cently been corroborated by Overhand t al19 who 
have reported that in the X-ray structure (figure 4) 
of a furanoid sugar amino acid containing gram-
cidin S analog 4 (figure 4), an intramolecular hy-
drogen bond between the sugar ring OH and the 
GaaNH helps the molecule to adopt a well-defined 
reverse-turn structure. 
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Figure 6. Linear tetramers of Gaa 5 (top) and their structures determined by NMR and constrained 
MD studies. Middle: Schematic representation of the proposed consecutive 10-membered b-turn like 
structures of 5; Bottom-left: Stereo view of the backbone-superimposed nergy-minimized structures 
of 5a, sampled during the constrained MD simulation studies (for clarity, the C3 and C4 atoms of the 
sugar rings carrying the O-Bn groups are not shown); Bottom-right: Full view of the energy-mini-
mized structure of one of the samples from the MD studies of 5a.20 
 
 
 Based on the conformational studies carried out 
by us and others, today we can generalize the struc-
tural preferences in peptides containing furanoid 
sugar amino acids and their imino-congeners as 
shown in figure 5. Peptides with 2,5-anhydro fura-
noid sugar amino acids A (figure 5), or having their 
imino congeners B, adopt 9-membered pseudo â-turn 
structures in which the AAi+2-NH form intramolecu-
lar hydrogen bond with the AAi (Saa) ring hydroxyl, 
C3-OH, only when the ring hydroxyl groups are free 
and have a cis-relationship with the adjacent car-
boxyl function, i.e. in 2,3-cis sugars. 
 However, when these ring hydroxyls are protec-
ted, or even absent as in their 3,4-dideoxy versions, 
the peptides containing these scaffolds show the 
propensity to form regular b-turn structures stabi-
lized by intramolecular hydrogen bond between 
AA i+1-NH ® AA i–1-CO (AAi is Saa) in those with 
2,5-anhydro sugars having either 2,3-cis or trans, 
but strictly a 2,5-cis relationship (C in figure 5) and 
between AAi+2-NH   pyrrolidine-N-CO in 2,5-imino 
sugar containing peptides having either 2,3-cis or 
trans orientation (D in figure 5). 
 In the Gaa homooligomers 5 (figure 6),20 even 
when the ring hydroxyls are free they do not partici-
pate in intramolecular H-bonds, like in A in figure 
5, because the AAi+2-NH is absent in these molecules. 
They, however, form the regular b-turn structures as 
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shown in figure 6 with intramolecular hydrogen 
bond between GaaiNH ® Gaai-2CO, irrespective of 
whether the hydroxyls are free or protected, provided 
the Saa units maintain the required 2,5-cis relation-
ship. Detailed NMR and constrained molecular  
dynamics (MD) simulation studies support the pres-
ence of consecutive 10-membered b-turn like struc-
tures in 5, which resemble a helical conformation 
throughout the molecule. Similar structures with re-
peating b-turns were found earlier by Fleet and co-
workers in their conformational studies with the 
acetate and acetonide protected oligomers of Gaa 
and other Saa with 2,5-cis junctions, the details of 
which have been r cently reported.21 
 Similar structures are expected for the homooligo-
mers of other “2,5-cis” furanoid sugar amino acids 
and also possibly in those furanoid sugar amino 
acid-containing peptides with no AAi+2 amide pro-
ton. This generalized concept as detailed above is 
very helpful in designing analogs of biologically  
active peptides based on these multifunctional scaf-
folds and mimic their secondary structures. 
 Further guidance for designing sugar amino acid 
containing analogs of small peptides to mimic their 
bioactive conformations can be provided by the finer 
details of the structural elements, especially the pro-
pensities of the j, y torsional angles shown by vari-
ous sugar amino acids in these peptides, which could 
be generalized based on the conformational studies, 
already carried out by us and others, of many such 
substrates. For example, the j y torsional angles of 
Gaa and some other furanoid sugar amino acids in 
various peptidomimetic analogs whose structures 
were studied by us are shown in table 1.
 It was observed by us earlier15 that in the four  
average structures (like A in figure 5) of Leu- nke-
phalin analog Boc–Tyr–Gaa–Phe–Leu–OMe 3 (fig-
ure 3) obtained during its constrained MD studies, 
y(Tyr) and j1(Gaa) variations are coupled and two 
of the four average structures show flip in the corre-
sponding amide plane (figure 3). The y(Tyr) and 
j1(Gaa) of the first two are around –80° and 85° res-
pectively, while the same for both the 3rd and the 
4th are around 105° and -92° respectively. Thus, 
the flip of the amide bond takes place due to Gaa 
through a 180° change of sequential y nd j dihe-
dral angles. Such flips are responsible for changes in 
conformations of proteins through switch in turn 
structures. The j, y torsional angles of the corres-
ponding Iaa containing analog, Boc–Tyr–Iaa–Phe–
Leu–OMe, in its five average structures obtained 
during the MD studies do not show any amide bond 
flip as is observed in the Gaa-based analog.15 
 In the regular b-turn structures (like C in figure 5) 
with protected ring hydroxyls as in compound 5a, 
Gaa displays j, y torsional angles –81×2, 62×7, 
-133×7, 4×1.20 More interestingly, in a related study 
recently carried out by us (last two entries in table 
1), and the results of which are yet to be published, 
the dideoxy sugar amino acid (2S,5R)-ddSaa displays 
torsional angles -96×6, 149×0, 110×0, -14×3, which 
are, to a certain extent, comparable to those for an 
ideal type II b-turn, -60, 120, 80, 0. Insertion of 
(2S,5R)-ddSaa is, thus, expected to induce structures 
having j, y torsional angles in the b-r gion of the 
Ramachandran plot. The (2R,5S)-ddSaa, on the 
other hand, have j, y torsional angles similar to 
those displayed by 5a, having the same stereochem-
istries at 2- and 5-positions of the sugar ring. Similar 
information about the structural preferences shown 
by other members of the family helps in choosing 
the appropriate sugar amino acid to mimic the re-
ceptor-bound conformations of small peptides. 
3. Changes in the 1H NMR chemical shifts  
of the ring hydroxyl protons due to the  
participation of the hydroxyl oxygens in  
H-bondings 
Another interesting observation made for the first 
time by us was that the chemical shifts of the prot ns 
of the ring hydroxyl groups involved in the intra-
molecular hydrogen bonds, as depicted in A and B 
in figure 5, consistently show significant downfiel  
shifts by up to 0×6 ppm in DMSO-d6 in the 1H NMR 
spectra of the furanoid sugar amino acid cont ining 
peptidomimetic molecu s compared to the chemical 
shifts of the non-hydrogen bonded hy roxyl protons 
present on the same sugar ring. The downfield shifts 
of the H-bonded hydroxyl protons are probably due 
to the decreased electron density on the hydroxyl 
hydrogens when the oxygen atoms act as H-bond 
acceptors to the amide protons. The extent of the 
downfi ld shift of the proton signal of the H-bonded 
OH is directly dependent on the strength of the H-
bond, measured by the temperature coefficients of 
the amide proton chemical shifts (Dd/DT). Lower 
the value of the temperature coefficient, stronger is 
the H-bond and consequently, the larger is the 
downfield shift of the OH proton signal. The 1H 
NMR chemical shifts, in DMSO-d6, of the protons 
of H-bonded and non-H-bonded hydroxyl groups in 
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Table 1. The average j,y torsional angles of Gaa and some other furanoid sugar 
amino acids in various peptidomimetic analogs. 
 
 
 
  Torsional angles (in degrees) 
 
 j1 y1 j2 y2 
 
Compound 3containing Gaa and with structure as in A in figure 5 (ref. 15) 
1st av. structure 80×4 52×9 -153×8 22×1 
2nd av. structure 98×1 58×7 -151×8 26×3 
3rd av. structure -93×2 58×8 -127×4 29×1 
4th av. structure -90×9 59×1 -147×2 25×7 
Analog of 3 containing Iaa and with structure as in A in figure 5 (ref. 15) 
Av. values 104×2 -61×4 -105×3 21×0 
Compound 5a, Gaa tetramer with structure as in C in figure 5 (ref. 20) 
Av. values -81×2 62×7 -133×7 4×1 
Leu–Met-(3,4-dideoxy Saa)-Thr–Tyr–Leu–Lys containing (2S,5R)-ddSaa and with 
structure as in C in figure 5
Av. values -96×6 149×0 110×0 -14×3 
Leu–Met-(3,4-dideoxy Saa)-Thr–Tyr–Leu–Lys containing (2R,5S)-ddSaa and with 
structure as in C in figure 5
Av. values -93×2 61×1 -104×2 3×9 
 
 
various molecules whose structures have been stud-
ied and the temperature coefficients (Dd/DT) of their 
H-bonded amide proton chemical shifts, wherever 
they are available, are listed in table 2. It should  
be noted here that these hydroxyl proton signals  
are not well detected in CDCl3. To the best of our 
knowledge, no such finding has been reported  
earlier on the characteristic downfield shifts of  
the protons of intramolecularly hydrogen-bond d 
hydroxyls.22 
 While the amide protons as H-bond donors can be 
identified easily by variable temperature studies, it 
is not always easy to locate their corresponding do-
nors by any direct evidence. The downfield shifts of 
the hydroxyl protons described here are a very use-
ful diagnostic tool, which, together with the charac-
t ristic ROE cross-peaks, can help to establish if such
ring hydroxyl groups as in sugar amino acids are in-
deed involved in intramolecular hydrogen bonding 
or not. For example, as already stated above in the 
Gaa homooligomers,20 even when the ring hydrox-
yls are free they do not participate in intermolecular 
H-bond, like the one in A in figure 5, because the 
AA i+2-NH is absent in these molecules. This is evi-
dent from the 1H NMR spectrum of Boc-(Gaa)4-
OMe 5c (figure 6) in DMSO-d6 that does not show 
any noticeable downfield shift of any of its OH pro-
ton signals, which appear in the range of 5×06–
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Table 2. Comparison between the 1H NMR chemical shifts of the H-bonded and non-H-bonded hydroxyl hydrogens 
and the temperature coefficients (Dd/DT in ppb/K) of the H-bonded amide protons in furanoid sugar amino acids co-
taining peptides, ~ 2–10 mM in DMSO-d6. 
  1H chemical shift of the
  H-bonded OH proton (d) 1H chemical shift of the 
  and Dd/DT (ppb/K) of the non H-bonded OH 
Peptides  H-bonded amide proton proton (d) Ref. 
 
 5×97 
 (Gaa C3-OH)  
  5×34 15 
 Dd/DT (ppb/K) of (Gaa C4-OH) 
 LeuNH = -1×3 
 
 
 5×71 
 (Iaa C3-OH)  
  5×26 15b 
 Dd/DT (ppb/K) of (Iaa C4-OH) 
 LeuNH = -2×0 
 
 
 5×89 
 (Gaa C3-OH) 
  5×29 23 
 Dd/DT (ppb/K) of (Gaa C4-OH) 
 LeuNH = -1×7 
 
 
 5×49 
 (GaaI C3-OH) 
   5×18 
 Dd/DT (ppb/K) of (GaaI C4-OH) 
 LeuINH = -2×7  
    23 
 5×59 
 (GaaII C3-OH) 
   5×18 
 Dd/DT (ppb/K) of  (GaaII C4-OH) 
 LeuIINH = -2×2 
 
 5×99 
 (Idac C3, C4-OH) 
 C2-symmetric 
    15b, 24 
 Dd/DT (ppb/K) of 
 LeuNH = -1×2 
 
 
 5.96 
 (Idac C3, C4-OH) 
 C2-symmetric 
    24 
 Dd/DT (ppb/K) of 
 LeuNH = -2×8 
 
(Continued on next page) 
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Table 2. (Continued) 
  1H chemical shift of the 
  H-bonded OH proton (d) 1H chemical shift of the 
  and Dd/DT (ppb/K) of the non H-bonded OH 
Peptides  H-bonded amide proton proton (d) Ref. 
 
 5×75 
 (sugar C3-OH) 
  Dd/DT (ppb/K) of 
 Leu(I)NH = -3×4 
    25 
 5×83 
 (sugar C4-OH) 
 Dd/DT (ppb/K) of 
 Leu(I¢)NH = -3×5 
 
 
  5×90  19 
  (sugar C3-OH) 
 
 
 
 
 
5×27 ppm, except the C-terminal Gaa(IV)C3-OH 
proton.20 The C-terminal Gaa(IV)C3-OH proton in 
this molecule resonates at 5×52 ppm, possibly due to 
an intramolecular 6-membered H-bond with the  
adjacent cis-ester group. 
4. Furanoid and pyranoid d-sugar amino acids 
and their uses in peptidomimetic studies 
Kessler and others26 reported an improved method 
for the synthesis of pyranoid d-sugar amino acid 6 
and used the same in the synthesis of cyclopeptides 
7 (figure 7) by a combination of solid-phase synthe-
sis and solution chemistry.26 Structural analysis re-
veals that 6 does not act as a b-turn mimetic in the 
cyclopeptide, cyclo (6-L-Lys-6-D-Phe). 
 In our laboratory, we have carried out struct ral 
studies of a furanoid sugar amino acid based peptide 
Boc–Gaa–Phe–Leu–OMe 8 and its dimer Boc–
(Gaa–Phe–Leu)2–OMe 9 (figure 8).
23 In CDCl3, they 
display very ordered structure with a repeating b-
turn-type secondary structure at lower concentra-
tions as hown in figure 8 and start forming aggre-
gates that gradually turn into excellent organogels as 
the concentrations are increased, a phenomenon  
observed for the first time in sugar amino acid-con-
taining peptides. 
 
Figure 7. Pyranoid d-sugar amino acid 6 and the cy lo-
peptides 7 prepared from 6.26 
 
 While scanning electron microscopic (SEM) 
analysis of the xerogels from 8 shows porous 3D 
structure (figure 9, left), SEM images of the gels 
from 9 (figure 9, right) reveal compact three-dimen-
sional fibrous structures that are wavy and tend to 
form helices where they are loose.23 
5. Cyclic homooligomers of furanoid and pyra-
noid d-sugar amino acids 
In ecent years, chemists have developed a large  
variety of oligomeric compounds that mimic bio-
polymers.3–5,27,28 Such synthetic oligomers are com-
posed of unnatural and yet nature-like monomeric 
building blocks assembled together by iterative syn-
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thetic processes that are amenable to combinatorial 
strategies. The main objective in developing such 
oligomers is to mimic the ordered secondary struc-
tures displayed by biopolymers and their functions. 
They are also expected to be more stable toward 
proteolytic cleavage in physiological systems than 
their natural counterparts. Rationally chosen mon -
meric units from the large repertoire of structurally 
diverse building blocks are woven together in speci-
fic sequences by iterative synthetic methods leading 
to the development of novel homo- and heteropoly-
mers with architecturally beautiful 3-D structures 
and desirable propeties. 
 In continuation of our work on designing sugar 
amino acid-based molecules, we were interested in  
 
 
 
Figure 8. Glucose-derived furanoid sugar amino acid, 
Gaa-based peptide Boc–Gaa–Phe–Leu–OMe 8 and its 
dimer Boc–(Gaa–Phe–Leu)2–OMe 9 and the schematic 
representation of their structures in CDCl3.
23 
 
 
 
Figure 9. SEM pictures of xerogels from 8 (left) and 9 
(right) in CHCl3.
23 
the synthesis and structural studies of acyclic and 
cyclic oligomers of furanoid sugar amino acids and 
related compounds. While the oligomerization of 6-
amino-2,5-anhydro-6-deoxy-D-mannonic acid Maa 
and the structural studies of the oligomers were  
described earlier,10a,b structural studies of the linear 
oligomers of 6-amino-2,5-anhydro-6-deoxy-D-glu-
onic acid Gaa20 has been discussed here in detail 
above (figure 6). Next, we focused our attention on 
the synthesis of cyclic homooligomers of furanoid 
sugar amino acids. Cyclization of linear peptides or 
covalent bridging of their constituent amino acids at 
appropriate places is a widely us d method to con-
strain their conformational degrees of freedom and 
in uce desirable structural biases essential for their 
biological activities, such as tubular structures for 
transporting ions or molecules across membranes. 
 In our laboratory, the cyclic homooligomers of 
mannose-derived furanoid sugar amino acid Maa 
were synthesized following a novel reaction that 
converts the sugar amino acid monomer directly 
into its cyclic homooligomers 10 and 11 (figure 
10).29 The glucose-based sugar amino acid Gaa under 
the same reaction conditions gives a bicyclic lactam 
12 as the major product. Cyclic homooligomers of 
Gaa were prepared by cyclizing their linear precur- 
 
 
 
Figure 10. Cyclic homooligomers of furanoid sugar 
amino acids.29 
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sors leading to the formation of cyclic peptides 13 
and 14. Addition of the bicyclic lactam 12 results in 
the influx of Na+ ions across the lipid bilayer leading 
to the dissipation of valinomycin- ediated K+ diffu-
sion potential.29 
 Conformational analysis by NMR and constrained 
MD studies reveal that all the cyclic products have 
symmetrical structures. While in the Maa trimer 10 
(figure 11, top), the C2-H and CO are placed on one 
side of the ring and the NHs point to the other side, 
the amide protons in the Maa tetramer 11 point into 
the ring and the carbonyls to the outside (figure 11, 
middle). In the Gaa dimer 13 (figure 11, bottom), 
 
 
 
Figure 11. Superimposition of the energy-minimized 
structures sampled during the constrained MD simula-
tions of 10 (top), 11 (middle) and 13(bottom).29 
 
 
 
Figure 12. Cyclic homooligomers 15 of pyranoid d-sugar 
amino acid 6.30 
the 12-membered core ring is flanked on two sides 
by furanoid rings in which the C2-hydrogens and 
the COs can be seen on one side of the ring and the 
NHs point to the other side.
 Earlier, cyclic homooligomers 15 (figure 12) of 
pyranoid d-sugar amino acid 6 were prepared by 
Kessler and others30 by solid- and solution-phase 
coupling procedures. The compounds show interes-
ing structural properties.30 The molecular struc ure 
of the cyclic oligomer in the all-syn conformation 
for the trimeric sequence generates a hydrophilic ex-
te ior surface and a nonpolar interior cavity, which 
has a cyclodextrin-type molecular shape. Its all-anti 
conformation leads to a flat structure in which the 
characteristic sequence of alternating ether and am-
ide linkages arranged in a symmetrical array make 
them ideal macrocyclic chelating agents as revealed 
by the NMR titration studies of the cyclic hexamer. 
Specifically, the dcrease in the diffusion value of 
the benzoic acid in the presence of the cyclic hexa-
mer suggests its action as cyclodextrin-like artifcial 
receptor. 
6. Furanoid and pyranoid d-sugar amino acids  
(d-Saa) with glycosyl amines 
Sugar amino acids with glycosyl amines have been 
prepared by many groups: (i) by reacting a reducing 
sugar with ammonia or ammonium hydrogen carb -
nate; (ii) by reducing glycosyl azides; (iii) by acidic 
ring opening of an -oxazoline.31 Recently, van der 
Marel and Overhand’s group has synthesized fura-
noid 16 and pyranoid d-Saa 17 (figure 13) bearing 
an amine group at the anomeric position using the 
Curtius rearrangement as the key step.31 These scaf-
folds are inserted into Leu-enkephalin replacing its  
 
 
 
Figure 13. Sugar amino acids with glycosyl amines 16 
and 17 used to make Leu-enkephalin analogs 18 and 19, 
respectively.31 
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Figure 14. b- and g-Sugar amino acids (20 and 21 respectively); the mixed, 
linear and cyclic oligomers from b-Saa and b-hGly (22 and 24 respectively); 
the mixed, linear oligomer from ã-Saa and GABA (23) and the somatostatin 
analog 25 containing the b-Saa.32,33 
 
Gly–Gly moiety. The resulting analogs 18 and 19 do 
not show any activity. 
7. b- and g-sugar amino acids 
Kessler and coworkers32 eported the development 
of two new sugar amino acids – a b-Saa 20 and a  
g-Saa 21 (figure 14). The mixed, linear oligomer of 
b-Saa and b-hGly (b-homoglycine or b-alanine), 
Fmoc-[b-Saa-b-hGly]3-OH 22 displays the 12/10/ 
12-helical structure in CH3CN as determined by 
NMR studies and subsequent simulated annealing 
and MD calculations. By contrast, the mixed linear 
oligomer of g-Saa and GABA (g-amino butyric acid), 
Fmoc-[g-Saa-GABA]3-OH 23 does not form any 
stable conformation in solution. The cyclic oligomer 
cyclo[b-Saa-b-Gly]3 24 exhibits a C3 symmetric 
conformation on the NMR chemical shift time scale. 
Earlier, the b-Saa 20 was used by Kessl r to prepare 
the somatostatin analog 25 that showed antiproli-
ferative and apoptotic activity against both multi-
drug-resistant and drug-sensitive hepatoma carci-
noma cells.33 
8. Furanoid and pyranoid e-sugar amino acids 
(e-Saa) 
Overhand’s group developed furanoid (26) and  
pyranoid (27) e-sugar amino acids that were used to 
prepare their cyclic homooligomers 28 and 29 res-
pectively (figure 15).34 An unrestrained simulated 
annealing technique was used to search the entire 
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conformational space in order to compare the con-
formational behaviour of these cyclic homoolig -
mers. While the five-m mbered rings in the cyclic 
trimer in 28 flip between twist (north, P = 0°) and 
envelope (south, P = 167°) conformations, the pyra-
noid rings in 29 adopt chair conformations stabi-
lized by the equatorial positions of all the hydroxy  
 
 
Figure 15. Furanoid and pyranoid e-sugar amino acids 
(26 and 27 respectively) and their cyclic homooligomers 
(28 and 29 respectively).34 
groups. The trimer in 29 with pyranoid rings is less 
flexible than that in 28 with furanoid Saa. In both 
y lic trimers the oxygen atoms in the sugar rings are 
located in their interior and the secondary hydroxyls 
are oriented outwards. The structure of the furanoid 
sugar amino acid trimer is compact and does not 
contain any water-accessible cavity. On the other 
hand, the pyranoid sugar amino acid trimer does 
possess a small cavity. Both the furanoid and pyra-
noid trimers have flat structures. 
 The furanoid e-Saa 26 was used to prepare some 
cyclic RGD peptidomimetic molecules 30–34 and a 
cyclic peptide 35 (figure 16) by solid-phase method 
using a cyclization-cleavage protocol.35 These mole-
cules were tested to ascertain their abilities to bind 
to the integrin receptors avb3 and aIIbb3. The cyclic 
tetrapeptide 30 show the most promising activity in 
an inhibition assay with an IC50 of 1×49 mM for the 
avb3 receptor and 384 nM for the aIIbb3 receptor. 
NMR-based molecular dynamics simulations and 
empirical calculations of the cyclic tetramer 35 show 
that it is conformationally restrained with the two 
Saa units adopting different conformations.36 One of 
them forms an unusual turn, stabilized by an intra-
residue nine-member hydrogen bond as shown in 36
 
 
Figure 16. Cyclic RGD peptidomimetic molecules 30–34 and a cyclic tetramer 35 
containing furanoid e-Saa 26 and the nine-member H-bonded ring structure 36,  
nucleated in the cyclic peptides 30 and 35 by the furanoid e-Saa.35,36 (Reprinted with 
permission from Am. Chem. Soc. (2003) vol. 125(36), pp 10822–29, © 2003 American 
Chemical Society.) 
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Figure 17. Bridged d- and e-sugar amino acids 37–39 and the Leu-enkephalin ana-
log 40 containing the d-Saa 37.37 
 
 
Figure 18. Structures of carbasugar diacid based pepti-
domimetic molecule 41 and its imino congener based 
compounds 42–43.25,38 
 
in figure 16. The X-ray crystal structure of 35 
strongly resembles its solution conformation. Con-
formational analysis of the biologically most active 
RGD analog 30 also reveals the presence of 36-type 
H-bonded structure in the molcule.36 
9. Bridged d- and e-sugar amino acids 
Overhand and van der Marel’s group also reported 
the synthesis of conformationally constrained bridged 
d- and e-sugar amino acids 37–39 (figure 17) and 
one of them (37) was used in the synthesis of the 
Leu-enkephalin analog 40.37 
10. Peptidomimetic studies with carbasugar 
and imino sugar based molecules 
Conformational analysis of the furanoid d-sugar 
amino acid based molecules, especially those with 
2,5-anhydro framework, as summarized in figure 5, 
encouraged us to examine the structural behaviour 
of their carbasugar and 2,5-imino sugar-based con-
geners. Consequently, we undertook the synthesis 
and conformational analysis of the carbasugar and 
imino sugar-based molecules 41 and 42–43 respecti-
vely, as shown in figure 18.38,25 While the former 
displays a structure which has a folded conformati  
involving an interstrand H-bond,38 the latter show 
two different conformations that switch from one to 
the other depending on whether the ring hydroxyls 
are protected or not.25 The design of the novel mole-
cular framework of pyrrolidine dicarboxylic acid 
with bi-directional dispositions of “hydroxy-D-pro-
line” moieties will enable us to study the conforma-
tional bias conferred by it when inserted in peptides. 
It is also expected to provide an insight into the role 
of the hydroxyl groups on the structures of hydroxy-
proline containing peptides. 
 Conformational analysis by NMR studies reveals 
that compounds 42b and 42c take interesting turn 
structures (C2 symmetric for 42c) in DMSO-d6 con-
sisting of identical intramolecular hydrogen bonds 
at two ends between LeuNH and sugar-OH, as depi-
cted in structure B in figure 5 and depicted here 
schematically in figure 19, whereas 42a displays 
structures with regular b-turns with hydrogen bonds 
between LeuNH and Boc-C=O in one half of their 
molecular framework (structure D in figure 5), char-
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acteristic of the turn structures commonly observed 
in “D-Pro-Gly” containing peptides.25 It is remark-
able that the protection–deprotection of the hydroxyl 
groups on pyrrolidine ring can make these pepti-
domimetic molecules switch from one conformation 
to another that has the potential to lead to many use-
ful applications. 
 The structures sampled during the restrained MD 
calculations based on the ROESY cross-peaks found 
 
 
 
 
Figure 19. Schematic representation of the H-bonded 
structures in 42a and 42b with type II¢ b-turn conforma-
tion as seen in D-Pro–Gly containing peptides in the for-
mer and pseudo b-turn involving 9-membered H-bonded 
structures on both sides of the pyrrolidine ring in the lat-
ter. Structure of 42c, which is C2-symmetric is similar to 
that of 42b. 
for 42b in DMSO-d6 reveal an ensemble of struc-
tures as shown in figure 20, where the two peptide 
chains form cyclic conformations at both ends in-
volving hydrogen bonds between LeuNH and pyrro-
lidine-OH with fairly conserved structures observed 
in the central portion of the molecule and the varia-
tions localized mainly at the Leu side-cha ns.25 
11. Furan and pyrrole amino acids 
In connection with our work on furanoid sugar amino 
acid, we also developed some new peptide building 
blocks, for example, a novel furan amino acid, 5-
(aminomethyl)-2-furancarboxylic acid 44,39 which 
was formed as a by-product during the preparation 
of the 3,4-dideoxy furanoid sugar amino acids. Sub-
sequently, we prepared them in large quantities from 
D-fructose. We were interested in preparing cyclic 
homoligomers of this furan amino acid as it was 
envisaged by us that these cyclic homooligomers 
with structurally rigid molecular scaffolds could be 
moulded to build predisposed cavities of precise 
dimensions and thus provide attractive tools for 
studying diverse molecular recognition processes. 
The method that we followed for making these cy-
clic peptides is a novel cyclooligomerization process 
wherein the monomeric furan amino acid 44 is cy-
clized directly into its cyclic trimer 45 in 60–75% 
yield in a single step as shown in figure 21.39 This 
avoids the lengthy stepwise assembling of linear 
precursors, the process conventionally followed for 
synthesizing similar cyclic products. 
 This novel 18-membered cyclic homooligomer 45 
is found to be an excellent receptor for carboxylate 
binding having an association constant of 8×64 ´  
103 M–1 for tetrabutylammonium acetate in acetoni-
trile.39 
 
 
Figure 20. (Left) Stereoview of the 20 superim osed structures, sampled at 5 ps in ervals during 100 ps MD simu-
lations of 42b, subsequently energy-minimized and superimposed aligning the hydrogen-bonded parts. (Right) 
Energy-minimized structure of one of the samples from MD studies.25 
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 We have also designed pyrrole amino acid 46 
which is structurally similar to furan amino acids 44 
and used it as a conformationally constrained surro-
gate of the Gly-DAla dipeptide isostere in peptido-
mimetic studies leading to the synthesis of 
compounds 47–49 (figure 22).40,41 
 
 
 
Figure 21. Single-step cyclooligomerization of furan 
amino acid 44.39 
 
 
 
Figure 22. Pyrrole amino acid 46 and peptides 47–49 
based on it.40,41 
 
Figure 23. (a) Schematic representation of the propo-
sed structure of 49 with the long-range rOes seen in the 
ROESY spectrum. (b) One of the 50 energy-minimized 
structures of 49 sampled during the 300 ps simulated an-
nealing MD studies.41 
 
 
 
Figure 24. Methoxypyrrole amino acid 50 (MOPAS) 
and the peptides 51, 52 based on it.42 
(b) 
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Figure 25. Pyranoid sugar amino acids 53–56 comprisng of 2-amino-, 3-amino-, 4-amino- and 6-amino-
Glc-b-CO2H, respectively and their homooligomers, b (1 ® 2)-linked 57, b (1 ® 3)-linked 58, b (1 ® 4)-
linked 59, and b (1 ® 6)-linked 60.43 
 
 
 The rigid scaffold of the pyrrole amino acid forces 
compounds 47 and 48 to adopt structures, in CDCl3, 
that can possibly be attributed to a g-turn type struc-
ture involving intramolecular hydrogen bonding bet-
ween the pyrrole NH and the carbonyl of the 
previous residues.40 On the other hand, compound 
49 with a centrally located type II¢ b-turn nucleating 
D-Pro–Gly motif and repeating units of Paa dimers 
at both N- and C-termini, adopts a well-defined b-
hairpin conformation in nonpolar solvents, like 
CDCl3, as shown in figure 23. The D-Pro unit with a 
j value of + 60 ± 20° induces the expected reverse 
turn in the strand which is further stabilized by non-
covalent interactions facilitated by the near planar 
disposition of the Paa-dimers at both ends leading to 
the nucleation of the hairpin architecture.41 
 Our work on pyrrole amino acid has recently been 
extended by König and others42 who have prepared 
a substituted Paa, methoxypyrrole amino acids 50 
(MOPAS) and introduced them into small peptides 
51 and 52 with hairpin structures (figure 24). The 
intra- and intermolecular binding properties of this 
heterocyclic amino acid mimicking a dipeptido‚ b-
strand was investigated by NMR titration and X-ray 
crystal structure analysis. The data reveal a hydro-
gen- onding pattern that is complementary to a pep-
tide b-sheet. 
12. Various other oligomers of sugar amino  
acids 
Ichikawa’s group prepared a series of pyranoid 
sugar amino acids 53–56 comprising 2-amino-, 3-
amino-, 4-amino- and 6-amino-Glc-b-CO2H respec-
tively and constructed four types of homo-olig ers, 
b(1 ® 2)-linked 57, b(1 ® 3)-linked 58, b(1 ® 4)-
linked 59, and b(1 ® 6)-linked 60 (figure 25).43 CD 
and NMR spectral studies of these oligomers sugge-
sted that only the b(1® 2)-linked homo- ligomer 
57 possesses a helical structure that seems to be pre-
determined by the linkage position. Homo- ligomers 
with b(1 ® 2)-linkages 57 and b(1 ® 6)-linkages 
60 were also subjected to O-sulphation, and these 
O-sulphated oligomers are found to be able, in a 
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linkage-specific manner, to effectively inhibit L-
selectin-mediated cell adhesion, HIV infection, and 
heparanase activity without the anticoagulant activity 
associated with naturally occurring sulphated poly-
saccharides such as heparin. 
 Gervay-Hague’s group synthesized ten N-Fmoc-
protected pyranoid sugar amino acids that are amen-
able to solid-phase synthesis.44 The same group has 
also recently reported the synthesis of N-Fmoc-pro-
tected sugar amino acids derived from a-O-methoxy- 
and 2,3-dehydroneuraminic acids and used them in 
the preparation of two series of linear oligomers 61 
and 62 (figure 26) by solid-phase synthesis.45 The 
(1 ® 5)-linked amides of 2,3-dehydroneuraminic 
acid were further subjected to hydrogenation giving 
a third series of oligomers 63 with a b-hydride sub-
stituent at the anomeric carbon. A C-terminus e-
amino caproic acid, a hydrophobic linker that dimi-
nishes solvation relative to a simple primary amde, 
was introduced in all these oligomers in order to 
prevent fraying of the terminal residue, which might 
disturb important hydrogen-bonding interactions re-
quired for stable secondary structure. 
 Fleet’s group has used a furanose sugar amino 
acid as a library scaffold to illustrate their potential 
for derivatisation (figure 27).46 The resulting 99-
member library 64 contains three orthogonal points 
of diversification that allows easy access to ether  
and carbamates from a hydroxy moiety, a range of 
 
 
 
Figure 26. Various neuraminic acid-derived sugar amino 
acid oligomers.45 
ureas from an azide (via an amine), and a range of 
amides from a methyl ester. 
13. Some other notable works on sugar amino 
acids 
Mazur and others prepared some tetrahydropyran-
based peptidomimetic analogs of Phe–Arg–Trp, a 
truncated version of the melanocortin receptor mes-
sage sequence.47 These compounds were tested for 
their activities at the melanocortin receptors MC4R 
and MC1R. Two of these analogs 65 and 66 are 
based on sugar amino acid framework. 
 Figure 29 summarizes the work carried out by 
Koert and group.48 THF–gramicidin hybrids 69–71, 
with the L-THF amino acid 67 in positions 11 and 
12 and compounds 72–75 with the D-THF amino 
acid 68 in positions 10 and 11, were synthesized and 
their ion-channel properties were studied by single-
channel-current analysis. The replacement of posi-
tions 11 and 12 by the L-THF amino acid 67 gives a 
strongly reduced channel performance. In contrast, 
replacement of positions 10 and 11 by the D-THF 
amino acid 68 gives rise to new and interesting 
channel properties. For the permeability ratios, the  
 
 
 
Figure 27. 99-Member library prepared from furanoid 
sugar amino acid scaffold.46 
 
 
 
Figure 28. Pyranoid sugar amino acid based peptido-
imetic analogs 65, 66 of Phe–Arg–Trp, a truncated version 
of the melanocortin receptor message sequence.47 
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Figure 29. Synthesis and functional studies of THF-gramicidin hybrid ion channels.48 
 
 
ion selectivity shifts from Eisenman I towards Eis-
enman III selectivity and the channels display ms-
dynamics (short closings and openings). Most re-
markable is the asymmetric compound 75, which in-
serts selectively into a DPhPC membrane and 
displays voltage-directed gating dynamics. 
14. Oligomers of 6-amino-6-deoxyaldonic  
acids – Hydroxylated nylon 6 
Fleet’s group has recently reported a new class of 
sugar amino acids based on open-chain 6-amino-6-
deoxyaldonic acids 76, which can be considered 
monomeric building blocks for polyhydroxylated 
nylon 6 derivatives 77 (figure 30).49–53 They have 
prepared a large variety of linear and cyclic oligo-
mers, as for example compounds 78–82, based on 
these building blocks and studied the X-ray structu-
res of some of these molecules. 
15. Conclusion 
Sugar amino acids have emerged as an important 
class of multifunctional building blocks that have 
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Figure 30. Open-chain sugar amino acids 76 with 6-amino-6-deoxyaldonic acid frameworks as mono-
meric building blocks for fully hydroxylated nylon 6 derivatives 77 and some of their oligomers.49–53 
 
 
found wide-ranging applications. Besides being 
used in peptidomimetics as rigid templates capable 
of inducing secondary structures in peptides, the 
various functional groups on each of these sugar 
amino acids, espcially their amino and carboxyl 
termini can serve as adapters for solid-phase synthe-
tic methods providing opportunities to create librar-
ies of multifaceted molecules that may emulate the 
diversity of biopolymers. Cyclic oligomers of sugar 
amino acids can be moulded to build predisposed 
cavities of precise dimensions that are expected to 
provide useful tools as novel synthetic receptors to 
study diverse molecular recognition processes. The 
nonproteinogenic properties of sugar amino acids 
will render compounds incorporating them physio-
logically more stable. Optimum utilization of the 
molecular diversities of sugar amino acids and the 
efficiency and speed of solid-phase chemistry will 
lead to the development of more and more bioactive 
molecules. Designing such molecules on the black-
board, bringing them into existence by synthesising 
them in the laboratory, studying the three-dimensio-
nal structures and properties of these “Designer 
Molecules” holds much promise for the future of 
organic synthesis. 
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